Revenue Summary of Shanghai Model Organisms Center, Inc.

Shanghai Model Organisms Center, Inc.'s latest annual revenue in 2023 was 366.54 Million CNY , up 20.99% from previous year.
Shanghai Model Organisms Center, Inc.'s latest quarterly revenue in 2024 Q3 was 87.62 Million CNY , down -6.31% from previous quarter.
Shanghai Model Organisms Center, Inc. reported a annual revenue of 302.96 Million CNY in annual revenue 2022, up 10.06% from previous year.
Shanghai Model Organisms Center, Inc. reported a annual revenue of 275.26 Million CNY in annual revenue 2021, up 40.31% from previous year.
Shanghai Model Organisms Center, Inc. reported a quarterly revenue of 93.91 Million CNY for 2024 Q2, up 13.25% from previous quarter.
Shanghai Model Organisms Center, Inc. reported a quarterly revenue of 87.62 Million CNY for 2024 Q3, down -6.31% from previous quarter.

Annual Revenue Chart of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Historical Annual Revenue of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Year	Revenue	Revenue Growth
2023	366.54 Million CNY	20.99%
2022	302.96 Million CNY	10.06%
2021	275.26 Million CNY	40.31%
2020	196.19 Million CNY	26.74%
2019	154.8 Million CNY	27.47%
2018	121.44 Million CNY	59.18%
2017	76.29 Million CNY	26.07%
2016	60.51 Million CNY	33.29%
2015	45.4 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	82.93 Million CNY	-15.85%
2024 Q2	93.91 Million CNY	13.25%
2024 Q3	87.62 Million CNY	-6.31%
2023 Q4	98.55 Million CNY	13.01%
2023 Q1	87.3 Million CNY	-0.25%
2023 Q3	87.21 Million CNY	-6.69%
2023 Q2	93.47 Million CNY	7.06%
2023 FY	366.54 Million CNY	20.99%
2022 Q1	72.7 Million CNY	-15.0%
2022 FY	302.96 Million CNY	10.06%
2022 Q4	87.51 Million CNY	2.43%
2022 Q3	85.44 Million CNY	49.12%
2022 Q2	57.29 Million CNY	-21.19%
2021 FY	275.26 Million CNY	40.31%
2021 Q1	54.3 Million CNY	-21.33%
2021 Q2	67.49 Million CNY	24.29%
2021 Q3	67.92 Million CNY	0.64%
2021 Q4	85.53 Million CNY	25.92%
2020 Q3	49.73 Million CNY	28.47%
2020 Q1	38.71 Million CNY	0.0%
2020 Q4	69.02 Million CNY	38.79%
2020 FY	196.19 Million CNY	26.74%
2020 Q2	38.71 Million CNY	0.0%
2019 FY	154.8 Million CNY	27.47%
2018 Q2	26.43 Million CNY	0.0%
2018 FY	121.44 Million CNY	59.18%
2018 Q1	26.43 Million CNY	11.04%
2017 Q1	19.79 Million CNY	3.99%
2017 Q2	19.79 Million CNY	-0.0%
2017 Q3	23.8 Million CNY	20.27%
2017 Q4	23.8 Million CNY	0.0%
2017 FY	76.29 Million CNY	26.07%
2016 FY	60.51 Million CNY	33.29%
2016 Q4	19.03 Million CNY	0.0%
2016 Q3	19.03 Million CNY	69.59%
2016 Q2	11.22 Million CNY	-0.0%
2016 Q1	11.22 Million CNY	0.0%
2015 FY	45.4 Million CNY	0.0%

Peer Revenue Comparison of Shanghai Model Organisms Center, Inc.

Name	Revenue	Revenue Difference
Beijing Tiantan Biological Products Co., Ltd.	5.18 Billion CNY	92.924%
JiangSu WuZhong Pharmaceutical Development Co., Ltd.	2.22 Billion CNY	83.532%
Jinyu Bio-technology Co., Ltd.	1.59 Billion CNY	77.065%
Vcanbio Cell & Gene Engineering Corp., Ltd	1.58 Billion CNY	76.943%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	17.28 Billion CNY	97.879%
Zhejiang Ausun Pharmaceutical Co., Ltd.	816.76 Million CNY	55.122%
DaShenLin Pharmaceutical Group Co., Ltd.	24.43 Billion CNY	98.5%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	5.47 Billion CNY	93.307%
GuiZhou SanLi Pharmaceutical Co.,Ltd	1.61 Billion CNY	77.351%
Pulike Biological Engineering, Inc.	1.25 Billion CNY	70.739%
Beijing Konruns Pharmaceutical Co.,Ltd.	920.01 Million CNY	60.158%
Shanghai Hile Bio-Technology Co., Ltd.	240.72 Million CNY	-52.27%
Qingdao Vland Biotech INC.	1.18 Billion CNY	69.172%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.	784.34 Million CNY	53.267%
Aurisco Pharmaceutical Co.,Ltd.	1.26 Billion CNY	70.967%
Zhejiang East Asia Pharmaceutical Co., Ltd.	1.35 Billion CNY	72.977%
Hainan Huluwa Pharmaceutical Group Co., Ltd.	1.9 Billion CNY	80.76%
Mabwell (Shanghai) Bioscience Co., Ltd.	127.68 Million CNY	-187.069%
Beijing Hotgen Biotech Co., Ltd.	541.25 Million CNY	32.278%
Assure Tech (Hangzhou) Co., Ltd.	503.35 Million CNY	27.179%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.	1.02 Billion CNY	64.286%
Cabio Biotech (Wuhan) Co., Ltd.	443.8 Million CNY	17.407%
Shanghai Shen Lian Biomedical Corporation	301.48 Million CNY	-21.58%
Nanjing Vazyme Biotech Co., Ltd.	1.28 Billion CNY	71.443%
Shandong Kexing Bioproducts Co,.Ltd	1.25 Billion CNY	70.887%
Shanghai Junshi Biosciences Co., Ltd.	1.48 Billion CNY	75.281%
Suzhou Zelgen Biopharmaceuticals Co., Ltd.	385.41 Million CNY	4.895%
Xiamen Amoytop Biotech Co., Ltd.	2.1 Billion CNY	82.548%
Novogene Co., Ltd.	2 Billion CNY	81.692%
Shanghai ZJ Bio-Tech Co., Ltd.	268.13 Million CNY	-36.702%
Chengdu Olymvax Biopharmaceuticals Inc.	496.11 Million CNY	26.117%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd	1.01 Billion CNY	63.852%
Shanghai Haohai Biological Technology Co., Ltd.	2.63 Billion CNY	86.089%
Jiangsu Bioperfectus Technologies Co., Ltd.	403.17 Million CNY	9.085%
Jiangsu Aidea Pharmaceutical Co., Ltd.	411.32 Million CNY	10.887%
Chengdu Easton Biopharmaceuticals Co., Ltd.	1.11 Billion CNY	67.188%
Sinocelltech Group Limited	1.88 Billion CNY	80.579%
Wuhan Keqian Biology Co.,Ltd	1.06 Billion CNY	65.552%
Shanghai Allist Pharmaceuticals Co., Ltd.	1.99 Billion CNY	81.595%
Anhui Huaheng Biotechnology Co., Ltd.	1.93 Billion CNY	81.089%
Youcare Pharmaceutical Group Co., Ltd.	4.19 Billion CNY	91.265%
Jiangsu gdk Biotechnology Co., Ltd.	134.59 Million CNY	-172.342%
Beijing Kawin Technology Share-Holding Co., Ltd.	1.41 Billion CNY	74.041%
Hangzhou Biotest Biotech Co.,Ltd.	442.11 Million CNY	17.091%

Global Stocks Search

Shanghai Model Organisms Center, Inc. (688265.SS)

Revenue Summary of Shanghai Model Organisms Center, Inc.

Annual Revenue Chart of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Historical Annual Revenue of Shanghai Model Organisms Center, Inc. (2023 - 2015)

Peer Revenue Comparison of Shanghai Model Organisms Center, Inc.